20892 ⎘
Medicinal preparations containing peptides Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
Sub-classes:PRE-MEDICATION AND IMPROVED TREATMENT REGIMEN
#2INTEGRIN INHIBITORS AS THERAPY FOR OBESITY DISORDERS
#3ANTIMICROBIAL BLOCK POLYPEPTIDE, THERAPEUTIC COMPOSITION INCLUDING THEREOF, AND METHOD FOR TREATING BACTERIAL GASTROINTESTINAL INFECTION USING THEREOF
#4Compositions for Treating Pathological Calcification Conditions, and Methods Using Same
#5BONE TARGETED TREATMENT IN OSTEOGENESIS IMPERFECTA
#6ANTIFUNGAL AGENTS AND USES THEREOF
#7PEPTIDE INHIBITORS TARGETING THE TBL1-BETA-CATENIN COMPLEX
#8NOVEL APPROACH FOR TREATMENT OF CANCER USING IMMUNOMODULATION
#9HYDROGEL INCLUSION COMPLEX INCLUDING PHYSIOLOGICALLY ACTIVE MATERIAL BOUND TO THERMOSENSITIVE POLY(PHOSPHAZENE) BY HOST-GUEST INTERACTION USING BETA-CYCLODEXTRIN AND USE THEREOF
#10PEPTIDES AND METHODS OF USE THEREOF IN TREATING OCULAR DISORDERS
#11ANG (1-7) DERIVATIVE OLIGOPEPTIDES AND METHODS FOR USING AND PRODUCING THE SAME
#12METHODS OF GENERATING POPULATIONS OF TUMOUR-INFILTRATING T CELLS
#13SYSTEMS AND METHODS FOR TREATMENT OF HEARING USING DIHEXA
#14PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS
#15POLYPEPTIDE, POLYPEPTIDE FRAGMENT, DERIVATIVE THEREOF, AND APPLICATIONS THEREOF
#16PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING ULCER OR FISTULA IN INTESTINAL TRACT
#17NOVEL IMMUNOTHERAPEUTIC MOLECULES AND USES THEREOF
#18NOVEL IMMUNOTHERAPEUTIC MOLECULES AND USES THEREOF
#19IMMUNOTHERAPEUTIC MOLECULES AND USES THEREOF
#20USE OF CNS-HOMING TARGETING PEPTIDES FOR TREATING NEUROLOGICAL DISORDERS
#21Polypeptide inhibitor of de novo lipogenesis in cancer cells
#22POLYPEPTIDES INCLUDING A BETA-TRICALCIUM PHOSPHATE-BINDING SEQUENCE AND USES THEREOF
#23MODIFIED EGFR ANTIBODY WITH REDUCED AFFINITY, DRUG CONJUGATE, AND USE THEREOF
#24PREBIOTIC COMPOSITIONS AND METHOD FOR WEIGHT LOSS BY USING THE SAME
#25APPROACH FOR TREATMENT OF CANCER VIA IMMUNOMODULATION BY USING TALABOSTAT
#26Peptides
#27CHIMERIC CONJUGATES FOR DEGRADATION OF VIRAL AND HOST PROTEINS AND METHODS OF USE
#28Antagonism of the VIP Signaling Pathway
#29METHOD FOR RAPID IN VITRO SYNTHESIS OF GLYCOPROTEINS VIA RECOMBINANT PRODUCTION OF N-GLYCOSYLATED PROTEINS IN PROKARYOTIC CELL LYSATES
#30CCN3 and CCN3 peptides and analogs thereof for therapeutic use
#31DIAGNOSTICS AND USE OF QUORUM SENSING MOLECULES IN MUSCLE WASTING
#32INHIBITION OF CYTOKINE-INDUCED SH2 PROTEIN IN NK CELLS
#33TOPICALLY APPLICABLE PREPARATION COMPRISING PEPTIDES AS ALLERGEN PROTECTION FOR THE SKIN
#34Compounds with Antimicrobial Properties
#35TREATMENT
#36Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells
#37TREM-1 INHIBITORS FOR THE TREATMENT OF VASO-OCCLUSIONS AND TISSUE INJURIES IN PATIENTS SUFFERING FROM SICKLE CELL DISEASE
#38LAG3 binding peptides
#39Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells
#40Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells
#41USE OF MELANOCORTINS TO TREAT INSULIN SENSITIVITY
#42PEPTIDES HAVING INHIBITORY ACTIVITY ON NEURONAL EXOCYTOSIS
#43Inhibition of cytokine-induced SH2 protein in NK cells
#44TARGET PEPTIDES FOR CANCER THERAPY AND DIAGNOSTICS
#45Peptide epoxyketone proteasome inhibitors in combination with PIM kinase inhibitors for treatment of cancers
#46Hemostatic composition and hemostatic method using hemostatic composition
#47PEPTIDE HAVING HAIR GROWTH PROMOTING ACTIVITY, AND USE THEREOF
#48Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells
#49Materials and Methods for Treatment of Inflammation
#50Dietary peptides
#51GLP-1 SECRETION-PROMOTING COMPOSITION
#52Polypeptides including a beta-tricalcium phosphate-binding sequence and uses thereof
#53Therapeutic Compositions Directed To Host Mirna For The Treatment Of Sars-Cov-2 (Covid-19) Infection
#54ANTIFUNGAL AGENTS AND USES THEREOF
#55A PHARMACEUTICALLY ACTIVE SUBSTANCE
#56NOVEL BIOMOLECULE CONJUGATES AND USES THEREFOR
#57Compositions for treating pathological calcification conditions, and methods using same
#58Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
#59Immunotherapeutic molecules and uses thereof
#60Compositions and Methods for Uncoupling TrkB Receptor from PLC Gamma 1 for the Treatment of Epilepsy and Anxiety-Like Disorder
#61Polypeptide, polypeptide fragment, derivative thereof, and applications thereof
#62PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS
#63Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
#64Inhibition of cytokine-induced SH2 protein in NK cells
#65Inhibition of cytokine-induced SH2 protein in NK cells
#66Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
#67Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
#68Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
#69Ang (1-7) derivative oligopeptides and methods for using and producing the same
#70AGONISTS OF GUANYLATE CYCLASE AND THEIR USES
#71Peptides and combination of peptides for use in immunotherapy against Hepatocellular carcinoma (HCC) and other cancers
#72Ligand controling interaction between gags with their effector molecules and use thereof
#73PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING ULCER OR FISTULA IN INTESTINAL TRACT
#74METHODS OF TREATING DRY EYE SYNDROME
#75Inhibition of cytokine-induced SH2 protein in NK cells
#76PEPTIDES DERIVED FROM ACTIN-LIKE PROTEIN 8 (ACTL8)
#77Method for rapid in vitro synthesis of glycoproteins via recombinant production of n-glycosylated proteins in prokaryotic cell lysates
#78POLYPEPTIDE INHIBITOR OF DE NOVO LIPOGENESIS IN CANCER CELLS
#79Methods of treating a wasting syndrome, increasing growth hormone levels, and increasing GHSR activity with a LEAP2 antibody
#80Peptides Having Anti-Inflammatory Properties
#81Methods of reducing neuroinflammation or toxicity induced by amyloid beta (abeta) using glucocorticoid induced leucine zipper (GILZ) analog peptides
#82HYDROGEL INCLUSION COMPLEX INCLUDING PHYSIOLOGICALLY ACTIVE MATERIAL BOUND TO THERMOSENSITIVE POLY(PHOSPHAZENE) BY HOST-GUEST INTERACTION USING BETA-CYCLODEXTRIN AND USE THEREOF
#83WNT5A PEPTIDES IN REDUCTION OF CANCER STEM CELLS
#84HYBRID MU OPIOID RECEPTOR AND NEUROPEPTIDE FF RECEPTOR BINDING MOLECULES, THEIR METHODS OF PREPARATION AND APPLICATIONS IN THERAPEUTIC TREATMENT
#85NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS
#86METHOD OF TREATING A LIVER DISEASE COMPRISING ADMINISTERING OSTREOLYSIN ORFUNCTIONALLY RELATED VARIANT THEREOF
#87COMPOSITIONS, ARTICLES OF MANUFACTURE AND METHODS FOR TREATING CANCER
#88NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS
#89LAG3 binding peptides
#90Materials and methods for treatment of inflammation
#91Peptide for suppressing osteoclast differentiation and use thereof
#92AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF OPIOID INDUCED DYSFUNCTIONS
#93Esculentin 1a derivatives and uses thereof
#94Treating Renal and Liver Dysfunction with TLR4 Antagonists
#95Preventive and/or therapeutic agent for osteogenesis imperfecta and other diseases
#96COMPOSITIONS AND METHODS FOR TREATING CANCER
#97COMPOSITIONS AND METHODS FOR TREATING CANCER
#98COMPOSITIONS AND METHODS FOR TREATING CANCER
#99COMPOSITIONS AND METHODS FOR TREATING CANCER
#100COMPOSITIONS AND METHODS FOR TREATING CANCER
#101Compositions and methods for treating cancer
#102Compositions and methods for treating cancer
#103Compositions and methods for treating cancer
#104Compositions and methods for treating cancer
#105Compositions and methods for treating cancer
#106Compositions and methods for treating cancer
#107Polypeptides including a beta-tricalcium phosphate-binding sequence and uses thereof
#108PEPTIDE EPOXYKETONE PROTEASOME INHIBITORS IN COMBINATION WITH PIM KINASE INHIBITORS FOR TREATMENT OF CANCERS
#109Methods for treatment of HBV infection
#110COMPOSITIONS AND METHODS FOR TREATING CANCER
#111Methods, compositions, and kits for detection of aspergillosis
#112COMPOSITIONS AND METHODS FOR TREATING CANCER
#113Compositions and methods for treating cancer
#114COMPOSITIONS AND METHODS FOR TREATING CANCER
#115Compositions and methods for treating cancer
#116Compositions and methods for treating cancer
#117Compositions and methods for treating cancer
#118Compositions and methods for treating cancer
#119Ang (1-7) derivative oligopeptides and methods for using and producing the same
#120Peptide agonists and antagonists of TLR4 activation
#121Methods for treating pseudoxanthoma elasticum (PXE)
#122Universal vaccine based on shared tumor neoantigens for prevention and treatment of micro satellite instable (MSI) cancers
#123PEPTIDES HAVING OSTEOBLAST GROWTH-PROMOTING ACTIVITY AND USE THEREOF
#124Compositions for treating pathological calcification conditions, and methods using same
#125Methods for treatment of nephrotic syndrome and related conditions
#126Method of treating a liver disease comprising administering ostreolysin orfunctionally related variant thereof
#127Agonists of guanylate cyclase and their uses
#128CCN3 and CCN3 peptides and analogs thereof for therapeutic use
#129Mixtures of sabadilla alkaloids and and uses thereof
#130FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHODS OF USE
#131Repair peptide for use in promoting post-traumatic tissue repair and regeneration, and application thereof
#132IMMUNOTHERAPY AGAINST MELANOMA AND OTHER CANCERS
#133Compositions and methods for uncoupling TrkB receptor from PLC gamma 1 for the treatment of epilepsy and anxiety-like disorder
#134C3A receptor agonists for use against ischemic brain injury, stroke, traumatic brain injury, spinal cord injury and neurodegenerative disorders
#135Peptides for treating Sjogren's syndrome
#136Immunotherapy against melanoma and other cancers
#137Immunotherapy against melanoma and other cancers
#138SYSTEM AND METHOD FOR ARRESTING DEBILITATING MIGRAINE EVENTS
#139COMPOSITIONS USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS
#140Plexin binding regulator
#141Methods of treating dry eye syndrome
#142Compositions for treating pathological calcification conditions, and methods using same
#143Discovery of cationic nonribosomal peptides as Gram-negative antibiotics through global genome mining
#144PEPTIDE EPOXYKETONE PROTEASOME INHIBITORS IN COMBINATION WITH PIM KINASE INHIBITORS FOR TREATMENT OF CANCERS
#145Methods for identifying and treating cachexia or pre-cachexia using an inhibitor of rage
#146Treatment of liver, biliary tract and pancreatic disorders
#147Non-standard insulin analogues
#148Tissue protective peptides for preventing and treating diseases and disorders associated with tissue damage
#149Glucosamine peptide compounds for treating liver metabolic disorders
#150Use of Melanocortins to Treat Insulin Sensitivity
#151NANO-SIZED DRUG DELIVERY STRUCTURE
#152Polypeptide inhibitors of SMAD3 polypeptide activities
#153Immunotherapy against melanoma and other cancers
#154Peptides and methods for treatment of neurodegenerative diseases
#155Peptides Having Anti-Inflammatory Properties
#156Immunotherapy against melanoma and other cancers
#157Immunotherapy against melanoma and other cancers
#158Immunotherapy against melanoma and other cancers
#159Immunotherapy against melanoma and other cancers
#160Peptides derived from actin-like protein 8 (ACTL8)
#161METHODS OF GENERATING POPULATIONS OF TUMOUR-INFILTRATING T CELLS
#162Inhibitors of the Interaction BCL-2 L10 / IP3 Receptors
#163NOVEL BIOMOLECULE CONJUGATES AND USES THEREFOR
#164Polypeptide for inhibition of tumor
#165Biomarker of Survival in the Treatment of Renal Cell Carcinoma with a VEGFR Inhibitor and an Ang2 Inhibitor
#166NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS
#167LEAP2 binding agents and compositions thereof
#168THERAPEUTIC PEPTIDES AND METHODS OF USE THEREOF
#169Dietary peptides
#170Esculentin 1a derivatives and uses thereof
#171Hemostatic composition and hemostatic method using hemostatic composition
#172Bacteriocidal peptides and uses thereof
#173Broken or folded helical peptide or peptide analog exhibiting antimicrobial activity against gram-negative bacteria, and use thereof
#174Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease
#175Modifications of cupredoxin derived peptides
#176Therapy and kit for the prevention and treatment of cystic fibrosis
#177Use of Melanocortins to Treat Insulin Sensitivity
#178Inhibition of cytokine-induced SH2 protein in NK cells
#179Protein based adhesive composition and method
#180Pharmaceutical formulations for the oral delivery of peptide drugs
#181Treating hyperammonemia, reducing plasma ammonia with TLR4 antagonists
#182Cytotoxic HEXIM1 peptides and uses thereof
#183Immunity to folate receptors
#184Environmentally sensitive compositions comprising a pH-triggered membrane protein and methods of use thereof in the treatment and diagnosis of tumors
#185Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
#186NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS
#187Phages of biomarker capture and methods of use
#188Immunotherapy against melanoma and other cancers
#189POLYPEPTIDE SPECIFICALLY BINDING TO CD34 MOLECULE AND USE THEREOF
#190Compositions, articles of manufacture and methods for treating cancer
#191Compositions and methods for treating cancer
#192Antimicrobial peptides and their use for the treatment of topical infections
#193Adhesive peptide and use therefor
#194Ezetimibe-associated ApoA-I mimetic peptides showing enhanced synergism
#195CDCA1-derived peptide and vaccine containing same
#196Compositions for treating pathological calcification conditions, and methods using same
#197Compositions for treating pathological calcification conditions, and methods using same
#198Compositions for treating pathological calcification conditions, methods, and host cells using the same
#199Ang (1-7) derivative oligopeptides and methods for using and producing the same
#200Saury Maillard peptide and its preparation method and application
#201Peptides for the treatment of malignant proliferative diseases
#202MCJ agonists and uses therefor
#203Method for rapid in vitro synthesis of glycoproteins via recombinant production of -glycosylated proteins in prokaryotic cell lysates
#204Mixtures of sabadilla alkaloids and and uses thereof
#205Method of treating overweight or obesity comprising administering a pleurotus ostreatus mushroom extract or a composition comprising a pleurotus ostretus mushroom extract
#206Method for the preparation of N-acetyl cysteine amide
#207PEPTIDES BASED ON THE TRANSMEMBRANE DOMAIN OF A TOLL-LIKE RECEPTOR (TLR) FOR TREATMENT OF TLR-MEDIATED DISEASES
#208Universal cancer peptides derived from telomerase
#209Compositions for treating pathological calcification conditions, and methods using same
#210Compositions for treating pathological calcification conditions, and methods using same
#211Composition containing thymosin beta 4, and pharmaceutical formulation comprising same
#212Treatment for chronic kidney disease
#213Sprr1A as a genetic target for treating neurodegenerative diseases
#214POLYPEPTIDES AND USES THEREOF AS A DRUG FOR TREATMENT OF AUTOIMMUNE DISORDERS
#215Approach for treatment of cancer via immunomodulation by using talabostat
#216SKIN PENETRATING PEPTIDES (SPPS) AND METHODS OF USE THEREFOR
#217Antagonism of the VIP signaling pathway
#218Polypeptide inhibitors of Smad3 polypeptide activities
#219METHODS AND COMPOSITIONS FOR ENHANCED DELIVERY OF COMPOUNDS
#220Methods and compositions for treating pain
#221Method for preparation of N-acetyl cysteine amide
#222Targeting of PELP1 in cancer therapy
#223Vaccines and compositions against
#224Treating liver diseases
#225Agonists of guanylate cyclase and their uses
#226Blood brain barrier shuttle
#227Crosslinked vaccination composition
#228Compositions and methods for treating hepatitis B
#229Methods, compositions, and kits for detection of aspergillosis
#230Peptides having anti-inflammatory properties
#231Compositions useful for the treatment of gastrointestinal disorders
#232Peptides having osteoblast growth-promoting activity and use thereof
#233Methods for treatment of nephrotic syndrome and related conditions
#234Use of melanocortins to treat insulin sensitivity
#235Method for promoting expression of calreticulin, and synthetic peptide for use in method for promoting expression of calreticulin
#236proteins, nucleic acids, and methods of their use
#237Environmentally sensitive compositions and methods of use thereof
#238Methods for treating spinocerebellar ataxia type I using RPA1
#239Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
#240S100 based treatment of cardiac power failure
#241Modified mini-hepcidin peptides and methods of using thereof
#242Method of treating cancer
#243Peptides and their use in the treatment of skin
#244Process for the manufacture of degarelix and its intermediates
#245Immunity to folate receptors
#246Peptides having anti-inflammatory properties
#247Cyclic cationic peptides with antimicrobial activity
#248Antifungal agents and uses thereof
#249Self-assembling peptide and polysaccharide complexes
#250Peptides with antifungal activity and methods of using the peptides
#251Vaccination composition
#252Use of melanocortins to treat insulin sensitivity
#253Formulations of guanylate cyclase C agonists and methods of use
#254CCN3 and CCN3 peptides and analogs thereof for therapeutic use
#255Therapy and kit for the prevention and treatment of cystic fibrosis
#256Compositions and methods for measles virus inhibition
#257Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof
#258Albumin fusion proteins
#259Anticonvulsant combination therapy
#260Peptide inhibitors as novel anti-HIV therapeutics
#261Methods and compositions for treating pain
#262Inflammation inhibiting compounds
#263Environmentally sensitive compositions and methods of use in the treatment and diagnosis of tumors
#264Method for identifying immunoreactive peptides
#265Antifungal agents and uses thereof
#266Compositions and methods for uncoupling TrkB receptor from PLC gamma 1 for the treatment of epilepsy and anxiety-like disorder
#267Netrin loop peptide mimetics and uses thereof
#268Peptides targeting receptor activator of nuclear factor-κB (RANK) and their applications
#269Compositions and methods for treating diseases
#270proteins, nucleic acids, and methods of their use
#271Compounds, compositions and methods for the treatment of diseases through inhibiting TGF-β activity
#272Modified mini-hepcidin peptides and methods of using thereof
#273Treatments for gastrointestinal disorders
#274Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof
#275Albumin fusion proteins
#276Methods and compositions for treating pain
#277Peptide-presenting surfaces for long-term culture of pluripotent cells
#278Compositions useful for the treatment of gastrointestinal disorders
#279Treatments for
#280Agonists of guanylate cyclase and their uses
#281Peptides that selectively home to heart vasculature and related conjugates and methods
#282Immunity to folate receptors
#283Methods for treatment of nephrotic syndrome and related conditions
#284Influenza inhibiting compositions and methods
#285Combined chemical modification of sphingosine-1-phosphate (S1P) and CXCR4 signalling pathways for hematopoietic stem cell (HSC) mobilization and engraftment
#286CETP fragments
#287Multimeric forms of antimicrobial peptides
#288Combination therapy and kit for the prevention and treatment of cystic fibrosis
#289Anticonvulsant combination therapy
#290Compositions and methods for coronavirus inhibition
#291Methods and compositions for targeting sites of neovascular growth
#292Treating renal and liver dysfunction with TLR4 antagonists
#293Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof
#294Antagonism of the VIP signaling pathway
#295Vaccine comprising Amb a 1 peptides for use in the treatment of ragweed allergy
#296Process for the manufacture of Degarelix and its intermediates
#297Process for the manufacture of Degarelix and its intermediates
#298Obesity-related genes and their proteins and uses thereof
#299Immunomodulatory methods and systems for treatment and/or prevention of aneurysms
#300Immunomodulatory methods and systems for treatment and/or prevention of hypertension